The KEYNOTE B36 study is a Phase 2 pilot, single-arm, open-label study designed to evaluate the safety and effectiveness of Tumor Treating Fields (TTFields), generated by the medical device NovoTTF-200T. Study patients use the device concomitant with pembrolizumab for...
Disease registry encompassing the care of patients with multiple myeloma on panobinostat. Participants will describe current treatment patterns and characterize adverse events in the first or later lines of therapy. Outcomes reported in RECOMM Registry
Phase 3 study comparing niraparib plus pembrolizumab versus placebo plus pembrolizumab as maintenance therapy for patients that have remained stable or responded to first line platinum based chemo plus pembrolizumab for stage IIIB or IV non-small cell lung cancer...
Pivotal, randomized, open-label study of Tumor Treating Fields (TTFields) concurrent with standard-of-care therapies for the treatment of stage 4 non-small cell lung cancer (NSCLC) following platinum failure.
Request An AppointmentNew patient appointments require a physician to send a referral request on your behalf. The referring physician can be a specialist you saw who identified an oncology-related condition or your primary care physician
New patient: you have a medical condition that is or could be cancerous or a blood disorder
Transfer care: you are moving into the area and need an oncologist/hematologist, or you are currently under the care of a local oncologist/hematologist and would like to transfer care to one of our physicians
2nd Opinion: you have been diagnosed with cancer or a blood disorder and would like to get a second opinion on the prognosis and treatment course
Former patient: if you have not been to the office in 3 years or more, you will need to get a referral sent in by a physician to re-establish care
Send the referral form to your physician to refer and ask them to send with the following items: